These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16172577)

  • 1. [Brain natriuretic peptide and heart failure].
    Camici M
    Minerva Med; 2005 Apr; 96(2):77-86. PubMed ID: 16172577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide in the contemporary management of congestive heart failure.
    Wasywich CA; Whalley GA; Doughty RN
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):71-84. PubMed ID: 15723576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Pros].
    Metra M; Nodari S; Pedrinazzi C; Rocca P; Manerba A; Vizzardi E; Danesi R; Dei Cas L
    Ital Heart J; 2003 Dec; 4 Suppl 8():59S-67S. PubMed ID: 15005534
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain natriuretic peptide and optimal management of heart failure.
    Li N; Wang JA
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):877-84. PubMed ID: 16130189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM; Zhang J; Deng B; Luo M
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of plasma B-type natriuretic peptide levels in cardiovascular diseases].
    Duygu H; Türk U; Zoghi M; Nalbantgil S
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):305-11. PubMed ID: 16330398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
    Morello AM; Januzzi JL
    Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in heart failure management.
    Isaac DL
    Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure.
    Mark PB; Petrie CJ; Jardine AG
    Semin Dial; 2007; 20(1):40-9. PubMed ID: 17244121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac natriuretic peptides in heart failure].
    Cvorisćec D; Cepelak I
    Lijec Vjesn; 2006; 128(9-10):279-85. PubMed ID: 17128666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of B-type natriuretic peptide predict poor clinical outcomes in patients with chronic and advanced heart failure.
    Sun TW; Wang LX
    Med Hypotheses; 2007; 68(3):677-9. PubMed ID: 16899344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide in heart failure and beyond.
    Mowla MM; Bustami BB
    Saudi Med J; 2006 Oct; 27(10):1457-61. PubMed ID: 17013463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with serum BNP (B type natriuretic peptide) in patients with systolic and diastolic heart failure].
    Lukács I; Fey E; Kárpáti P
    Orv Hetil; 2005 Sep; 146(37):1919-23. PubMed ID: 16255376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.
    Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A
    Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
    Rutten JH; Boomsma F; Van den Meiracker AH
    Ned Tijdschr Geneeskd; 2007 Nov; 151(46):2553-7. PubMed ID: 18074722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Cons].
    Andreuzzi B; Mangiavacchi M; Pini D; Municinò A; Genovese L; Tomaello L; Gronda E
    Ital Heart J; 2003 Dec; 4 Suppl 8():68S-72S. PubMed ID: 15005535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.